How Bayer Makes Decisions to Develop New Drugs - In Bayer Biological Products' first decision-analysis project, its strategic-planning department evaluated a new blood-clot-busting drug.
|Year of publication:||
|Authors:||Stonebraker, Jeffrey S.|
Interfaces : the INFORMS journal on the practice of operations research. - Linthicum, Md : INFORMS, ISSN 0092-2102, ZDB-ID 1207854. - Vol. 32.2002, 6, p. 77-90
Stonebraker, Jeffrey S., (2003)
ARTICLES - New York Power Authority Uses Decision An attempt to minimize damage to small fish Analysis to Schedule Refueling of Its Indian and fish eggs in scheduling power plant Point 3 Nuclear Power Plant shutdowns.
Dunning, Dennis J., (2001)
Stonebraker, Jeffrey S., (2009)
- More ...